CDKN1A and cancer: However, taking into consideration the extremely low incidence of p21 mutations in human cancer and the less drastic tumor-prone phenotype in p21-deficient mice in comparison to mice deficient in other tumor suppressors, such as p53 or p16, the tumor suppressive role of p21 is not viewed as crucial.